The following requirements must be complied with if you are to be considered fully vaccinated in relation to travel restrictions:
- The vaccine must be approved by the European Medicines Agency (EMA).
- At least two weeks must have passed since you completed a full course of the COVID-19 vaccine.
- No more than 12 months must have passed since you completed a full course of the COVID-19 vaccine.
- You must either provide proof that you are a Danish national, present an EU COVID-19 Vaccine Passport or provide proof that you are habitually resident in an EU or Schengen country, Andorra, San Marino, Monaco, the Vatican State, an orange OECD country or a yellow third country.
If your first dose was the AstraZeneca vaccine and your second dose was an mRNA vaccine (Spikevax (from Moderna) or Comirnaty (from Pfizer-BioNTech)), you are considered to have had a full course of the COVID-19 vaccine.
So far, the following COVID-19 vaccines have been approved by the EMA:
- Pfizer BioNtech (Comirnaty) (two doses required).
- Johnson & Johnson – Janssen Pharmaceuticals (COVID-19 Vaccine Janssen). (NOTE: Only one dose of the Janssen vaccine is required).
- Spikevax (formerly Moderna /COVID-19 Vaccine Moderna) (two doses required).
- AstraZeneca (Vaxzevria, formerly COVID-19 Vaccine AstraZeneca) (two doses required).
If you change the type of vaccination, the latest approved vaccination course is valid. The following cross-vaccinations may apply as a completed vaccination course:
- Pfizer BioNtech/Comirnaty + Spikevax/Moderna.
- AstraZenecca + Pfizer BioNtech/Comirnaty.
- AztraZenecca + Spikevax/Moderna.
As regards vaccines requiring two doses, you will only be considered fully vaccinated two weeks after the second shot.